Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Using a Fragment-Based Approach to Identify Alternative Chemical Scaffolds Targeting Dihydrofolate Reductase from Mycobacterium tuberculosis

Full text
Author(s):
Show less -
Ribeiro, Joao A. [1, 2] ; Hammer, Alexander [3] ; Libreros-Zuniga, Gerardo A. [2, 4, 5] ; Chavez-Pacheco, Sair M. [2] ; Tyrakis, Petros [6] ; de Oliveira, Gabriel S. [2] ; Kirkman, Timothy [7] ; El Bakali, Jamal [3] ; Rocco, Silvana A. [8] ; Sforca, Mauricio L. [8] ; Parise-Filho, Roberto [9] ; Coyne, Anthony G. [3] ; Blundell, Tom L. [6] ; Abell, Chris [3] ; Dias, Marcio V. B. [1, 6, 7, 2, 4]
Total Authors: 15
Affiliation:
[1] Univ Estadual Campinas, Inst Biol, BR-13083862 Campinas, SP - Brazil
[2] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, BR-05508000 Sao Paulo, SP - Brazil
[3] Univ Cambridge, Dept Chem, Cambridge CB2 1EW - England
[4] State Univ Sao Paulo, IBILCE, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP - Brazil
[5] Univ Valle, Dept Microbiol, Cali 760043 - Colombia
[6] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA - England
[7] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands - England
[8] Natl Lab Biosci, BR-13083100 Campinas, SP - Brazil
[9] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, BR-05508000 Sao Paulo, SP - Brazil
Total Affiliations: 9
Document type: Journal article
Source: ACS INFECTIOUS DISEASES; v. 6, n. 8, p. 2192-2201, AUG 14 2020.
Web of Science Citations: 0
Abstract

Dihydrofolate reductase (DHFR), a key enzyme involved in folate metabolism, is a widely explored target in the treatment of cancer, immune diseases, bacteria, and protozoa infections. Although several antifolates have proved successful in the treatment of infectious diseases, they have been underexplored to combat tuberculosis, despite the essentiality of M. tuberculosis DHFR (MtDHFR). Herein, we describe an integrated fragment-based drug discovery approach to target MtDHFR that has identified hits with scaffolds not yet explored in any previous drug design campaign for this enzyme. The application of a SAR by catalog strategy of an in house library for one of the identified fragments has led to a series of molecules that bind to MtDHFR with low micromolar affinities. Crystal structures of MtDHFR in complex with compounds of this series demonstrated a novel binding mode that considerably differs from other DHFR antifolates, thus opening perspectives for the development of relevant MtDHFR inhibitors. (AU)

FAPESP's process: 10/15971-3 - Structural characterization of enzymes from antibiotic biosynthetic pathways with biotechnological interest
Grantee:Marcio Vinicius Bertacine Dias
Support type: Research Grants - Young Investigators Grants
FAPESP's process: 13/15906-5 - Fragment based drug discovery (FBDD) applied to two enzymes of folate biosynthetic pathway from Mycobacterium tuberculosis
Grantee:João Augusto Ribeiro
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 18/00351-1 - Applied structural biology involved in the biosynthesis of natural products: biotechnolgical aplications and study of unusual molecular reactions
Grantee:Marcio Vinicius Bertacine Dias
Support type: Regular Research Grants